Characteristics Of Antibiotic-Resistant Escherichia Coli O157:H7 In Washington State, 1984–1991
The resistance of Escherichia coli O157:H7 to amoxicillin/clavulanic acid, ampicillin, ceftazidime, ceftriaxone, cefuroxime, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, streptomycin, sulfisoxazole, tetracycline, ticarcillin, tobramycin, and trimethoprim-sulfamethoxazole was examined, an...
Gespeichert in:
| Veröffentlicht in: | The Journal of infectious diseases 1994-12, Vol.170 (6), p.1606-1609 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1609 |
|---|---|
| container_issue | 6 |
| container_start_page | 1606 |
| container_title | The Journal of infectious diseases |
| container_volume | 170 |
| creator | Kim, Harold H. Samadpour, Mansour Grimm, Linda Clausen, Carla R. Besser, Thomas E. Baylor, Michael Kobayashi, John M. Neill, Marguerite A. Schoenknecht, Fritz D. Tarr, Phillip I. |
| description | The resistance of Escherichia coli O157:H7 to amoxicillin/clavulanic acid, ampicillin, ceftazidime, ceftriaxone, cefuroxime, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, streptomycin, sulfisoxazole, tetracycline, ticarcillin, tobramycin, and trimethoprim-sulfamethoxazole was examined, and resistant strains were characterized. All 56 isolates collected between 1984 and 1987 were susceptible to all antibiotics tested; 13 (7.4%) of 176 strains isolated between 1989 and 1991 were resistant to streptomycin, sulfisoxazole, and tetracycline. A-restriction fragment length polymorphism analysis suggested that the 13 resistant strains belonged to nine different clones. The emerging resistance of E. coli O157:H7 to antibiotics could portend an increased prevalence of this pathogen in food animals that receive antibiotics. Antimicrobial resistance of E. coli O157:H7 could be useful as a rapid epidemiologic marker and as a way to select this pathogen from suspected vehicles of transmission, but this resistance could also complicate therapeutic trials with sulfa-containing antibiotics. |
| doi_str_mv | 10.1093/infdis/170.6.1606 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_76887069</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30133681</jstor_id><sourcerecordid>30133681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-edc556cd2d45631b136b7a00024e634ef5d9126ed1ac0d1ca6a3ed5aa4bbb52d3</originalsourceid><addsrcrecordid>eNqFkc1uEzEURi0EKqHwACyQvECsmNR3PLbH7KqokIqg8A9iY92xPcRlMlNsR4Id78Ab8iS4SmiXrCz7nPvp6jMhD4HNgWl-EsbehXQCis3lHCSTt8gMBFeVlMBvkxljdV1Bq_Vdci-lC8ZYw6U6IkdKa8mYmBFcbDCizT6GlINNdN3T0zGHLkzlWr31qbzjmOlZspsi2U1AupiGQNcg1LOloucj_YRpE8aveRrpu4zZP6Wg2-bPr9-gNdwnd3ockn9wOI_Jh-dn7xfLarV-cb44XVW2aetceWeFkNbVrhGSQwdcdgrLxnXjJW98L5yGWnoHaJkDixK5dwKx6bpO1I4fkyf73Ms4fd_5lM02JOuHAUc_7ZJRsm0Vk_q_IsiW8YaJIsJetHFKKfreXMawxfjTADNX_Zt9_6b0b6S56r_MPDqE77qtd9cTh8ILf3zgmCwOfcTRloR_Gudc1lrcxFykPMUbzKAILRRe7Xn5Hf_jmmP8ZqTiSpjl5y8GXi8_sjevVuYl_wuXbqcD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16803405</pqid></control><display><type>article</type><title>Characteristics Of Antibiotic-Resistant Escherichia Coli O157:H7 In Washington State, 1984–1991</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Kim, Harold H. ; Samadpour, Mansour ; Grimm, Linda ; Clausen, Carla R. ; Besser, Thomas E. ; Baylor, Michael ; Kobayashi, John M. ; Neill, Marguerite A. ; Schoenknecht, Fritz D. ; Tarr, Phillip I.</creator><creatorcontrib>Kim, Harold H. ; Samadpour, Mansour ; Grimm, Linda ; Clausen, Carla R. ; Besser, Thomas E. ; Baylor, Michael ; Kobayashi, John M. ; Neill, Marguerite A. ; Schoenknecht, Fritz D. ; Tarr, Phillip I.</creatorcontrib><description>The resistance of Escherichia coli O157:H7 to amoxicillin/clavulanic acid, ampicillin, ceftazidime, ceftriaxone, cefuroxime, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, streptomycin, sulfisoxazole, tetracycline, ticarcillin, tobramycin, and trimethoprim-sulfamethoxazole was examined, and resistant strains were characterized. All 56 isolates collected between 1984 and 1987 were susceptible to all antibiotics tested; 13 (7.4%) of 176 strains isolated between 1989 and 1991 were resistant to streptomycin, sulfisoxazole, and tetracycline. A-restriction fragment length polymorphism analysis suggested that the 13 resistant strains belonged to nine different clones. The emerging resistance of E. coli O157:H7 to antibiotics could portend an increased prevalence of this pathogen in food animals that receive antibiotics. Antimicrobial resistance of E. coli O157:H7 could be useful as a rapid epidemiologic marker and as a way to select this pathogen from suspected vehicles of transmission, but this resistance could also complicate therapeutic trials with sulfa-containing antibiotics.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/170.6.1606</identifier><identifier>PMID: 7996005</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Antibacterial agents ; Antibiotic resistance ; Antibiotics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimicrobials ; Bacterial Toxins - genetics ; Biological and medical sciences ; Colitis ; Concise Communications ; DNA, Bacterial - analysis ; Drug Resistance, Microbial ; Escherichia coli ; Escherichia coli - classification ; Escherichia coli - drug effects ; Escherichia coli - genetics ; Escherichia coli Infections - microbiology ; Feces - microbiology ; Genes, Bacterial - genetics ; Genotype ; Humans ; Infections ; Labor standards ; Medical sciences ; Microbial Sensitivity Tests ; Pathogens ; Pharmacology. Drug treatments ; Plasmids ; Polymorphism, Restriction Fragment Length ; Public health ; Shiga Toxin 1 ; Shiga Toxin 2 ; Streptomycin - pharmacology ; Sulfisoxazole - pharmacology ; Tetracycline - pharmacology ; Washington</subject><ispartof>The Journal of infectious diseases, 1994-12, Vol.170 (6), p.1606-1609</ispartof><rights>Copyright 1994 The University of Chicago</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-edc556cd2d45631b136b7a00024e634ef5d9126ed1ac0d1ca6a3ed5aa4bbb52d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30133681$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30133681$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3336295$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7996005$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Harold H.</creatorcontrib><creatorcontrib>Samadpour, Mansour</creatorcontrib><creatorcontrib>Grimm, Linda</creatorcontrib><creatorcontrib>Clausen, Carla R.</creatorcontrib><creatorcontrib>Besser, Thomas E.</creatorcontrib><creatorcontrib>Baylor, Michael</creatorcontrib><creatorcontrib>Kobayashi, John M.</creatorcontrib><creatorcontrib>Neill, Marguerite A.</creatorcontrib><creatorcontrib>Schoenknecht, Fritz D.</creatorcontrib><creatorcontrib>Tarr, Phillip I.</creatorcontrib><title>Characteristics Of Antibiotic-Resistant Escherichia Coli O157:H7 In Washington State, 1984–1991</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>The resistance of Escherichia coli O157:H7 to amoxicillin/clavulanic acid, ampicillin, ceftazidime, ceftriaxone, cefuroxime, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, streptomycin, sulfisoxazole, tetracycline, ticarcillin, tobramycin, and trimethoprim-sulfamethoxazole was examined, and resistant strains were characterized. All 56 isolates collected between 1984 and 1987 were susceptible to all antibiotics tested; 13 (7.4%) of 176 strains isolated between 1989 and 1991 were resistant to streptomycin, sulfisoxazole, and tetracycline. A-restriction fragment length polymorphism analysis suggested that the 13 resistant strains belonged to nine different clones. The emerging resistance of E. coli O157:H7 to antibiotics could portend an increased prevalence of this pathogen in food animals that receive antibiotics. Antimicrobial resistance of E. coli O157:H7 could be useful as a rapid epidemiologic marker and as a way to select this pathogen from suspected vehicles of transmission, but this resistance could also complicate therapeutic trials with sulfa-containing antibiotics.</description><subject>Antibacterial agents</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimicrobials</subject><subject>Bacterial Toxins - genetics</subject><subject>Biological and medical sciences</subject><subject>Colitis</subject><subject>Concise Communications</subject><subject>DNA, Bacterial - analysis</subject><subject>Drug Resistance, Microbial</subject><subject>Escherichia coli</subject><subject>Escherichia coli - classification</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Feces - microbiology</subject><subject>Genes, Bacterial - genetics</subject><subject>Genotype</subject><subject>Humans</subject><subject>Infections</subject><subject>Labor standards</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Pathogens</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasmids</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Public health</subject><subject>Shiga Toxin 1</subject><subject>Shiga Toxin 2</subject><subject>Streptomycin - pharmacology</subject><subject>Sulfisoxazole - pharmacology</subject><subject>Tetracycline - pharmacology</subject><subject>Washington</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1uEzEURi0EKqHwACyQvECsmNR3PLbH7KqokIqg8A9iY92xPcRlMlNsR4Id78Ab8iS4SmiXrCz7nPvp6jMhD4HNgWl-EsbehXQCis3lHCSTt8gMBFeVlMBvkxljdV1Bq_Vdci-lC8ZYw6U6IkdKa8mYmBFcbDCizT6GlINNdN3T0zGHLkzlWr31qbzjmOlZspsi2U1AupiGQNcg1LOloucj_YRpE8aveRrpu4zZP6Wg2-bPr9-gNdwnd3ockn9wOI_Jh-dn7xfLarV-cb44XVW2aetceWeFkNbVrhGSQwdcdgrLxnXjJW98L5yGWnoHaJkDixK5dwKx6bpO1I4fkyf73Ms4fd_5lM02JOuHAUc_7ZJRsm0Vk_q_IsiW8YaJIsJetHFKKfreXMawxfjTADNX_Zt9_6b0b6S56r_MPDqE77qtd9cTh8ILf3zgmCwOfcTRloR_Gudc1lrcxFykPMUbzKAILRRe7Xn5Hf_jmmP8ZqTiSpjl5y8GXi8_sjevVuYl_wuXbqcD</recordid><startdate>19941201</startdate><enddate>19941201</enddate><creator>Kim, Harold H.</creator><creator>Samadpour, Mansour</creator><creator>Grimm, Linda</creator><creator>Clausen, Carla R.</creator><creator>Besser, Thomas E.</creator><creator>Baylor, Michael</creator><creator>Kobayashi, John M.</creator><creator>Neill, Marguerite A.</creator><creator>Schoenknecht, Fritz D.</creator><creator>Tarr, Phillip I.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19941201</creationdate><title>Characteristics Of Antibiotic-Resistant Escherichia Coli O157:H7 In Washington State, 1984–1991</title><author>Kim, Harold H. ; Samadpour, Mansour ; Grimm, Linda ; Clausen, Carla R. ; Besser, Thomas E. ; Baylor, Michael ; Kobayashi, John M. ; Neill, Marguerite A. ; Schoenknecht, Fritz D. ; Tarr, Phillip I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-edc556cd2d45631b136b7a00024e634ef5d9126ed1ac0d1ca6a3ed5aa4bbb52d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Antibacterial agents</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimicrobials</topic><topic>Bacterial Toxins - genetics</topic><topic>Biological and medical sciences</topic><topic>Colitis</topic><topic>Concise Communications</topic><topic>DNA, Bacterial - analysis</topic><topic>Drug Resistance, Microbial</topic><topic>Escherichia coli</topic><topic>Escherichia coli - classification</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Feces - microbiology</topic><topic>Genes, Bacterial - genetics</topic><topic>Genotype</topic><topic>Humans</topic><topic>Infections</topic><topic>Labor standards</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Pathogens</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasmids</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Public health</topic><topic>Shiga Toxin 1</topic><topic>Shiga Toxin 2</topic><topic>Streptomycin - pharmacology</topic><topic>Sulfisoxazole - pharmacology</topic><topic>Tetracycline - pharmacology</topic><topic>Washington</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Harold H.</creatorcontrib><creatorcontrib>Samadpour, Mansour</creatorcontrib><creatorcontrib>Grimm, Linda</creatorcontrib><creatorcontrib>Clausen, Carla R.</creatorcontrib><creatorcontrib>Besser, Thomas E.</creatorcontrib><creatorcontrib>Baylor, Michael</creatorcontrib><creatorcontrib>Kobayashi, John M.</creatorcontrib><creatorcontrib>Neill, Marguerite A.</creatorcontrib><creatorcontrib>Schoenknecht, Fritz D.</creatorcontrib><creatorcontrib>Tarr, Phillip I.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Harold H.</au><au>Samadpour, Mansour</au><au>Grimm, Linda</au><au>Clausen, Carla R.</au><au>Besser, Thomas E.</au><au>Baylor, Michael</au><au>Kobayashi, John M.</au><au>Neill, Marguerite A.</au><au>Schoenknecht, Fritz D.</au><au>Tarr, Phillip I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics Of Antibiotic-Resistant Escherichia Coli O157:H7 In Washington State, 1984–1991</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1994-12-01</date><risdate>1994</risdate><volume>170</volume><issue>6</issue><spage>1606</spage><epage>1609</epage><pages>1606-1609</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>The resistance of Escherichia coli O157:H7 to amoxicillin/clavulanic acid, ampicillin, ceftazidime, ceftriaxone, cefuroxime, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, streptomycin, sulfisoxazole, tetracycline, ticarcillin, tobramycin, and trimethoprim-sulfamethoxazole was examined, and resistant strains were characterized. All 56 isolates collected between 1984 and 1987 were susceptible to all antibiotics tested; 13 (7.4%) of 176 strains isolated between 1989 and 1991 were resistant to streptomycin, sulfisoxazole, and tetracycline. A-restriction fragment length polymorphism analysis suggested that the 13 resistant strains belonged to nine different clones. The emerging resistance of E. coli O157:H7 to antibiotics could portend an increased prevalence of this pathogen in food animals that receive antibiotics. Antimicrobial resistance of E. coli O157:H7 could be useful as a rapid epidemiologic marker and as a way to select this pathogen from suspected vehicles of transmission, but this resistance could also complicate therapeutic trials with sulfa-containing antibiotics.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>7996005</pmid><doi>10.1093/infdis/170.6.1606</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-1899 |
| ispartof | The Journal of infectious diseases, 1994-12, Vol.170 (6), p.1606-1609 |
| issn | 0022-1899 1537-6613 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_76887069 |
| source | MEDLINE; JSTOR Archive Collection A-Z Listing |
| subjects | Antibacterial agents Antibiotic resistance Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Antimicrobials Bacterial Toxins - genetics Biological and medical sciences Colitis Concise Communications DNA, Bacterial - analysis Drug Resistance, Microbial Escherichia coli Escherichia coli - classification Escherichia coli - drug effects Escherichia coli - genetics Escherichia coli Infections - microbiology Feces - microbiology Genes, Bacterial - genetics Genotype Humans Infections Labor standards Medical sciences Microbial Sensitivity Tests Pathogens Pharmacology. Drug treatments Plasmids Polymorphism, Restriction Fragment Length Public health Shiga Toxin 1 Shiga Toxin 2 Streptomycin - pharmacology Sulfisoxazole - pharmacology Tetracycline - pharmacology Washington |
| title | Characteristics Of Antibiotic-Resistant Escherichia Coli O157:H7 In Washington State, 1984–1991 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A38%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20Of%20Antibiotic-Resistant%20Escherichia%20Coli%20O157:H7%20In%20Washington%20State,%201984%E2%80%931991&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Kim,%20Harold%20H.&rft.date=1994-12-01&rft.volume=170&rft.issue=6&rft.spage=1606&rft.epage=1609&rft.pages=1606-1609&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/170.6.1606&rft_dat=%3Cjstor_proqu%3E30133681%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16803405&rft_id=info:pmid/7996005&rft_jstor_id=30133681&rfr_iscdi=true |